Literature DB >> 31377223

Diabetes, heart failure, and renal dysfunction: The vicious circles.

Eugene Braunwald1.   

Abstract

The prevalence of Type 2 diabetes mellitus (T2DM) has reached pandemic proportions. T2DM frequently causes macrovascular and/or microvascular pathologic changes and thereby increases the risks for the development of myocardial infarction, heart failure, stroke, renal failure, and reduced survival. This article describes the important interactions between T2DM, heart failure, and renal dysfunction, forming vicious circles. The interruption of these circles represents important therapeutic goals.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Chronic kidney disease; Diabetes mellitus; Diabetic kidney disease; Heart failure; Type 2 diabetes mellitus

Year:  2019        PMID: 31377223     DOI: 10.1016/j.pcad.2019.07.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  38 in total

Review 1.  [Artificial intelligence in cardiology : Relevance, current applications, and future developments].

Authors:  Bettina Zippel-Schultz; Carsten Schultz; Dirk Müller-Wieland; Andrew B Remppis; Martin Stockburger; Christian Perings; Thomas M Helms
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-01-15

2.  Impaired left atrial strain in the presence of interatrial block in patients with type 2 diabetes mellitus.

Authors:  Mustafa Dogdus; Ferhat Dindas; Onur Akhan; Mustafa Yenercag; Arafat Yildirim; Ozge Ozcan Abacioglu; Salih Kilic
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-06       Impact factor: 2.357

3.  Predicting Progression Patterns of Type 2 Diabetes using Multi-sensor Measurements.

Authors:  Ramin Ramazi; Christine Perndorfer; Emily C Soriano; Jean-Philippe Laurenceau; Rahmatollah Beheshti
Journal:  Smart Health (Amst)       Date:  2021-06-12

4.  Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Qian Wu; Yang Liu; Yu-Bo Ma; Kui Liu; Song-Hua Chen
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

Authors:  Kåre I Birkeland; Johan Bodegard; Jan W Eriksson; Anna Norhammar; Hermann Haller; Gerard C M Linssen; Amitava Banerjee; Marcus Thuresson; Suguru Okami; Elena Garal-Pantaler; Jetty Overbeek; Jil Billy Mamza; Ruiqi Zhang; Toshitaka Yajima; Issei Komuro; Takashi Kadowaki
Journal:  Diabetes Obes Metab       Date:  2020-06-03       Impact factor: 6.577

6.  Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years.

Authors:  Claire A Lawson; Samuel Seidu; Francesco Zaccardi; Gerry McCann; Umesh T Kadam; Melanie J Davies; Carolyn Sp Lam; Hiddo L Heerspink; Kamlesh Khunti
Journal:  EClinicalMedicine       Date:  2021-02-04

Review 7.  Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes.

Authors:  Yingjie Wu; An Zhou; Li Tang; Yuanyuan Lei; Bo Tang; Linjing Zhang
Journal:  J Diabetes Res       Date:  2020-07-17       Impact factor: 4.011

8.  The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.

Authors:  Ann Wan-Chin Ling; Cze-Ci Chan; Shao-Wei Chen; Yi-Wei Kao; Chien-Ying Huang; Yi-Hsin Chan; Pao-Hsien Chu
Journal:  Cardiovasc Diabetol       Date:  2020-11-06       Impact factor: 9.951

9.  Potential Molecular Mechanism of the NPPB Gene in Postischemic Heart Failure with and without T2DM.

Authors:  Yao-Zong Guan; Rui-Xing Yin; Guo-Xiong Deng; Peng-Fei Zheng; Chun-Xiao Liu; Bi-Liu Wei
Journal:  Biomed Res Int       Date:  2020-08-03       Impact factor: 3.411

10.  Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

Authors:  Kåre I Birkeland; Johan Bodegard; Amitava Banerjee; Dae Jung Kim; Anna Norhammar; Jan W Eriksson; Marcus Thuresson; Suguru Okami; Kyoung Hwa Ha; Nils Kossack; Jil Billy Mamza; Ruiqi Zhang; Toshitaka Yajima; Issei Komuro; Takashi Kadowaki
Journal:  Diabetes Obes Metab       Date:  2020-09-28       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.